Course Directors: William D. Freeman, M.D., Alfredo Quinones-Hinojosa, M.D., Joon H. Uhm, M.D., and Betty Kim, M.D., Ph.D.,
Co-Course Directors: Christina Smith, A.R.N.P. and Suzanne Beckman, R.N., SCRN
This course will provide attendees with an update in major areas of neuroscience and oncology research from basic science, translational laboratories and clinical trials research. Lectures will cover neuroscientific arenas including brain tumor biology and growth, vascular neogenesis, nanotechnology for tumor suppression, viral vectors for tumor destruction, and other new agents to target and destroy brain tumors. The conference will discuss basic tumors of the brain and other sites including breast in addition to metastatic brain tumor therapies. Also, the course will cover the latest diagnostic and therapeutic approaches to tumors. Lectures will be supplemented with high yield industry and CEO-level Q&A sessions, precision medicine, and patient and celebrity stories. Other high yield sessions will include governmental policy makers that are guiding brain tumor patient care for future health care systems.
Target audience:
This course is designed for neurologists, neurosurgeons, medical oncologists, neuropathologists, neurointerventional surgeons, radiation oncologists, pathologists, ARNPs/PAs, nurses and other healthcare personnel who are interested in this field.
Learning objectives:
Upon conclusion of this program, participants should be able to:
- Recognize the signs and symptoms of cancer and primary and metastic brain tumors
- Define tumor biology of primary and metastatic brain tumors as well as new scientific methods to destroy and neutralize tumor growth
- Provide cutting-edge updates in neuroscience, neuro-oncology, and oncologic biology research
- Outline U.S. health challenges in patient care for the future of those with brain and other tumors and cancer
For complete information, registration, etc. visit
https://ce.mayo.edu/content/mayo-clinic-neuroscience-and-oncology-innovation-summit-2017